|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/46 | (2006.01) |
| C12Y 301/03001 | (2013.01) | ||
| A61P 25/08 | (2006.01) | ||
| A61K 38/465 | (2013.01) | ||
| A61P 19/00 | (2018.01) | ||
| A61P 19/08 | (2018.01) | ||
| A61P 25/08 | (2018.01) | ||
| A61P 43/00 | (2018.01) |
| (11) | Number of the document | 3226891 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15825878.0 |
| Date of filing the European patent application | 2015-12-04 | |
| (97) | Date of publication of the European application | 2017-10-11 |
| (45) | Date of publication and mention of the grant of the patent | 2025-06-25 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/064003 |
| Date | 2015-12-04 |
| (87) | Number | WO 2016/090251 |
| Date | 2016-06-09 |
| (30) | Number | Date | Country code |
| 201462088025 P | 2014-12-05 | US | |
| 201562259307 P | 2015-11-24 | US |
| (72) |
MAROZSAN, Andre , US
DEVORE, Denise , US
LIU-CHEN, Susan , US
|
| (73) |
Alexion Pharmaceuticals, Inc. ,
121 Seaport Boulevard, Boston, MA 02210,
US
|
| (54) | TREATING SEIZURE WITH RECOMBINANT ALKALINE PHOSPHATASE |
| TREATING SEIZURE WITH RECOMBINANT ALKALINE PHOSPHATASE |